ClinicalTrials.gov and FDAAA - Applicable Clinical Trials (ACTs) under FDAAA
U.S. Department of Health & Human Services Logo
NIH > Office of Extramural Research Logo
Home About Grants Funding Forms & Deadlines Grants Policy News & Events About OER NIH Home
Grants and Funding
NIH Implementation of FDAAA
Identifying an "Applicable Clinical Trial" under FDAAA
  • This flow chart presents basic guidance on determining if a trial is considered an “applicable clinical trial” under FDAAA. It maps out the guidance provided in the "Elaboration of Definitions of Responsible Party and Applicable Clinical Trial" (PDF - 115 KB), and is also available as a PDF (393 KB).
  • This flow chart may not address every situation. The grantee's sponsored research office, general counsel, or other similar official should be involved in determining whether or not the grant supports an applicable clinical trial that needs to be registered under FDAAA.
Does the trial include a drug, biologic or device?






The NIH encourages registration and results reporting for all NIH-supported clinical trials, regardless of whether or not they are subject to FDAAA.

This page last updated on May 26, 2011
Content Manager: OEPMailbox@mail.nih.gov
Technical Issues: E-mail OER Webmaster

Social Media Links